Navigation Links
Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results
Date:11/6/2009

cs and VNS Therapy is available at www.cyberonics.com and

www.vnstherapy.com.

    CONTACT INFORMATION:
    Greg Browne, CFO
    Cyberonics, Inc.
    100 Cyberonics Blvd., Houston, TX 77058
    Main:  (281) 228-7262/Fax:  (281) 218-9332
    ir@cyberonics.com

SOURCE Cyberonics, Inc.


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Cyberonics Provides Update on Depression Post-Approval Study
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, UnitedStatesDentalDevicesMarketAnalysis....com/p0158733/United-States-Dental-Devices-Market-...tatesDentalDevicesMarketAnalysisandForecaststo2015...ceforin-depthinformationanddatarelatingtotheUSdent...
(Date:11/25/2009)...HAM,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniu...hnologymarketintelligence,thenearly$3billionUSmark...owthoverthenextfiveyearsdespitetherecenteconomicsl...tfindsthatthismarketwillremainhighlydynamicoverthe...ddevicesinpreviouslyunderservedsegmentsofthetrauma...
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, IntranasalDrugDelivery-USMarketTrends&a...Intranasal-Drug-Delivery---US-Market-Trends--Analy...switnessinganexpansionoftherapeuticapplicationsfro...hedeliveryofsystemictherapeuticdrugs.Thefutureofth...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 1U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 2U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 3ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 1ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 2ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 3GREENBioPharma Dec 2 3 2009 10591 1
...apentadol Efficacy and Tolerability for Acute Pain...ted that up to 30 percent of all people who have s...uch as nausea and vomiting. The use of opioid pain...isk factor for experiencing these side effects. Na... and can have an impact on a patient,s recovery. ,...
...l to be Held at 9:00 a.m. Eastern Time Today, May ...herapeutics Corporation (Nasdaq: UTHR ) announce...istration (FDA) has approved ADCIRCA(TM) (tadalafi...nded dose of 40 mg, as the first once-daily phosph...ent of pulmonary arterial hypertension (PAH). ADC...
Other Medicine Technology:New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4
(Date:11/25/2009)...ARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,alead...sandsoftwareandCalgaryScientificInc.,aleadingprovi...ebversionofAegis(TM)Breast4DAdvancedVisualizations...ulyzero-footprintWebclientbasedmedicalimagingoffer...ormallowsforzero-footprintaccess-requiringnosoftwa...
(Date:11/25/2009)...d.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJanet...ationandResearch,titled"ADifficultBalance-PainMana...09issueofTheNewEnglandJournalofMedicine. ,, (Lo...DALOGO ) ,, Inthearticle,WoodcockdiscussesFDAef...forthosewhoneeditandmanagingtherisksposedbyvarious...
(Date:11/25/2009)...lEndorsements,Business,andPressJoinEfforttoEducate.../--Onceagain,theNationalBipolarFoundationandtheMed...r"Safe,tilStable"program,whichisnowbeingwidelyacce...er.Today,theNationalBipolarFoundationreceivedaproc...fromtheLt.GovernorofLouisianaMitchLandrieu.TheNati...
(Date:11/25/2009)...very that grew out of a collaboration between UCLA...hope to the nearly 10 million Americans who suffer...own as hardening of the arteries, peripheral arter...em in which narrowed arteries reduce blood flow to... for vascular disease, heart attack and stroke, an...
(Date:11/25/2009)...d to fight rheumatoid arthritis, could help newly ...NESDAY, Nov. 25 (HealthDay News) -- A drug commonl...oid arthritis now also shows some promise in helpi..., The drug, rituximab (Rituxan), helped patient...hough the disease had destroyed some of their panc...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... MedicareSupplementPlans.co...nce agencies specializing in Medicare supplement i... cap on Medicare services and provide seniors with...ns.com: Legislation designed to remove Medicare&rs...
..., , , SCHAUMBURG, Ill., April 24 World Veterina...elationship between veterinarians and livestock fa...and Livestock Farmers: a winning , partnershi...cer of the American Veterinary Medical Association...
...SAN DIEGO - Researchers from the Children,s Cancer...n Cancer Center have discovered a new drug combina...uroblastoma, a childhood cancer. The study was pre...or, vandetanib, with 13-cis-retinoic acid (CRA), a...
...ditional impairment charge anticipated in the four...orium Group, Inc. (Nasdaq: ENCO ), a full servi...RO) that provides design, development, and managem... 2009 it received a letter from Nasdaq stating tha...
...mpany will showcase technologies for brachytherapy...c(TM) radiotherapy, and stereotactic body radiothe...an Medical Systems (NYSE: VAR ) will showcase th...n Chicago from April 25-30. , , "Varian offers st...
...ey finds that psychological needs are going unmet,...People with heart failure, and those who care for ...cal needs, a new study finds. , "Heart failure pat...lth Sciences Center, who was to present the study ...
Other Medicine News:Health News:MedicareSupplementPlans.com Says News Legislation Could Affect Physical, Speech Therapy Benefits for Medicare Recipients 2Health News:AVMA Celebrates World Veterinary Day 2Health News:Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation 2Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 2Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 3Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 4Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 2Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 3Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 4Health News:Reduce Suffering, Urge Heart Failure Patients and Caregivers 2Health News:Reduce Suffering, Urge Heart Failure Patients and Caregivers 3
CONCERT® Spine VR Bone Cement
...urgeon describes samples taken with,the new Comp...ns a,cleaner cut and larger sample for histopath...s optimized vacuum and cutting edge., Unique "O ...cuum,in the needle so that suction concentrates ...
CVC 9005 Hematocrit Calibration Verification Control (for use with the IRMA TRUpoint Blood Analysis System)
QC 233 CO-Oximeter Control
Medicine Products: